Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta‐Analysis

Abstract

Objective. Integrated therapy of traditional Chinese medicine (TCM) and Western medicine (WM) has gradually been applied to the treatment of rheumatoid arthritis (RA). Recently published studies have provided a wealth of data and information about the effectiveness of combination treatments, but high-quality evidence-based meta-analysis on this issue is not available yet. This study was conducted to compare and evaluate the efficacy and safety of the integrated therapy for RA. Methods. PubMed, EMBASE, and the Cochrane Library were searched up to January 2020. Randomized controlled trials (RCTs) that compared the efficacy and safety of integrative TCM-WM with WM alone for RA were included. The outcome measures contained therapeutic effects (TEs), tender joint count (TJC), swollen joint count (SJC), duration of morning stiffness (DMS), grip strength (GS), disease activity score in 28 joints (DAS28), rheumatoid factor (RF), anti-cyclic peptide containing citrulline (anti-CCP), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and adverse events (AEs) to assess the efficacy and safety of different treatments. Results. A total of 20 RCTs with 2269 patients met the inclusion criteria. TCM used in these studies included Chinese herbal decoctions and tablets or capsules made from herbs and their extracts, while WM included disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), and glucocorticoids (GC). Compared with patients receiving WM treatment alone, patients with integrative TCM-WM treatment showed better TEs (OR = 3.03, 95% CI [2.36, 3.88]). The integrative treatment group showed reductions in TJC (MD = −1.17, 95% CI [−2.12, −0.21]), SJC (MD = −0.87, 95% CI [−1.85, 0.10]), DMS (SMD = −0.69, 95% CI [−0.98, −0.41]), DAS28 (MD = −0.43, 95% CI [−0.57, −0.29]), RF (SMD = −0.59, 95% CI [−0.91, −0.27]), anti-CCP (SMD = −0.21, 95% CI [−0.36, −0.06]), ESR (MD = −8.36, 95% CI [−12.60, −4.12]), and CRP (MD = −6.73, 95% CI [−9.38, −4.08]), and increment in GS (SMD = 0.12, 95% CI [−0.63, 0.87]). AEs, especially gastrointestinal disorders, abnormal liver function, leukopenia, skin allergies and rashes, headaches and dizziness, and alopecia, significantly decreased (OR = 0.37, 95% CI [0.29, 0.47]) in the integrative treatment group. Conclusions. The findings of this meta-analysis indicate that integrative TCM-WM could obtain effective and safe results in the treatment of RA. Using TCM as an adjunctive therapy in RA has great prospects for further development.

The Role of Traditional Chinese Medicine in Arthritis Management: Why We Need Public Health and Health Services Research

“…Traditional Chinese medicine (TCM), a comprehensive medical health system including acupuncture, Chinese herbal medicine, Chinese therapeutic massage, Tai Chi, Qi Gong, and a range of other health modalities has attracted increasing attention from arthritis sufferers and healthcare providers (4). However, there is limited evidence supporting the efficacy of TCM treatments for arthritis (5)(6)(7). While those studies appealing to a restricted evidence-base (limited to efficacy and pursued via randomized controlled trials and other experimental designs) may dismiss complementary medicine and TCM as irrelevant to arthritis care and investigation, a significant number of people with arthritis do use TCM in addition to their conventional medical treatments.…”

Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial

“…Specifically, Qingre Huoxue decoction (QRHXD) may prevent bone destruction by modulating inflammation, and short-term application of a cream prepared from Tripterygium wilfordii —the source of a QRHXEP component—was shown to be an effective and safe adjunctive treatment ( Jiang et al, 2012 ; China Association of Chinese Medicine, 2017 ; Jiao et al, 2019 ). Oral Chinese medicines were found to relieve joint symptoms with minimal adverse reactions in combination with topical formulations for improved disease control ( Xing et al, 2020 ).…”

Network Pharmacology to Identify the Pharmacological Mechanisms of a Traditional Chinese Medicine Derived from Trachelospermum jasminoides in Patients with Rheumatoid Arthritis

“…Studies of complementary therapies such as traditional Chinese medicine (TCM) against RA have yielded promising results [ 8 ]. The TCM wind-dampness dispelling herbs have been commonly been used in managing RA in East Asia for a long time.…”